A study presented at the 2024 American Society of Hematology Annual Meeting & Exposition compared outcomes of patients with myelodysplastic syndromes (MDS) according to race and neighborhood-level socioeconomic (SE) data. The study utilized data from 2013 through 2023 from patients treated at the MD Anderson Cancer Center. Area deprivation index (ADI) data was collected. The researchers conducted propensity score matching for 366 non-Hispanic White patients and 61 non-Hispanic Black patients. Cytogenic risk groups were similar between racial groups, regardless of ...
Disparities in Blood Cancers
Advertisement
Black, Hispanic, and Asian patients were underrepresented in trials compared with national lymphoma data.
Families reported the direct cash support program offered them the “ability to spend more time at their child’s ...
Despite delays to infusion, response rates to CAR-T were comparable across racial groups.
The proportion of myeloma cases linked to BMI and diabetes was higher in Black patients than White patients.
Patients who were Black or female were more likely to refuse treatment for multiple myeloma.
The study looked at disparities in outcomes of infusion with ide-cel or cilta-cel in patients with relapsed or refractory MM.
Significant delays in diagnosing multiple myeloma exist.
Talquetamab is a promising treatment for relapsed multiple myeloma, however, it presents unique side effects.
Advertisement
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.